Switch to
More onapp

How to use scorecard? Learn more

Natco Pharma Ltd

NATCOPHARM
Health CarePharmaceuticals
SmallcapWith a market cap of ₹17,052 cr, stock is ranked 323
High RiskStock is 3.33x as volatile as Nifty
952.0521.45 (-2.20%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹17,052 cr, stock is ranked 323
High RiskStock is 3.33x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
13.34
PB RatioPB Ratio
3.50
Dividend YieldDiv. Yield
0.59%
Sector PESector PE
51.91
Sector PBSector PB
5.95
Sector Div YldSctr Div Yld
0.56%

Forecast & RatingsDetailed Forecast 

70%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Natco Pharma Limited is a research and development (R&D)-focused pharmaceutical company. The Company is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs).

Brands

Natco Pharma

Pharmaceutical company

Investor PresentationView older 

Aug 10, 2023

PDF
View Older Presentations

Brands

Natco Pharma

Pharmaceutical company

Financial TrendFinancial statements 

20202021202220232.022.162.042.810.460.440.170.72
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Decreased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has decreased by 2.46%

See detailed holdings

Recent EventsAll events 

Shareholders meeting 
Announced OnMar 27, 2024

Natco Pharma Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results along with copy of minutes. | Download

Natco Pharma Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results along with copy of minutes. | Download

Trading Window-XBRL 
Announced OnMar 26, 2024

NATCO PHARMA LIMITED has informed the Exchange about Closure of Trading Window | Download

NATCO PHARMA LIMITED has informed the Exchange about Closure of Trading Window | Download

Cash Dividend 
Ex. DateFeb 26, 2024

Interim 3 • Div/Share: ₹ 1.25

See all events